Photobiological regulation therapeutic instrument for treating age-related macular degeneration and use method

A technology for photobiomodulation and macular degeneration, applied in phototherapy and other directions, can solve problems such as cost and risk increase, and achieve the effect of low treatment cost, improved activity, and low price
CN112675435APending Publication Date: 2021-04-20FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIV
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN Β· China
Current Assignee / Owner
FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL UNIV
Publication Date
2021-04-20

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The invention discloses a photobiological regulation therapeutic instrument for treating age-related macular degeneration and a use method. According to the photobiological regulation therapeutic instrument, by setting near-infrared light with a wavelength of 600-800 nm relative to a brightness of left and right eye sight glasses, two eyes of a patient are treated under a light-emitting viewpoint for 4 times every day and 40 seconds every time, so that activity of mitochondrial cytochrome c oxidase is improved, energy supply and cell metabolism are increased, tissue metabolism repair is enhanced, cone cell death of age-related macular degeneration patients is slowed down, and greater possibility is provided for vision recovery of the patients. The photobiological regulation therapeutic instrument is high in safety, low in price of a low-dose red light therapeutic instrument, low in treatment cost of patients and beneficial to popularization.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a treatment device for age-related macular degeneration, in particular to a photobiomodulation treatment device for treating age-related macular degeneration and its application method. Background technique

[0002] Age-related macular degeneration (AMD) is an eye disease whose incidence is positively correlated with age. The medical community generally believes that the degeneration of photoreceptors and retinal pigment cells (RPE cells) in the macular area of ​​the retina is one of the pathogenic factors of AMD. As one of the irreversible blinding eye diseases, statistics show that 8.7% of the world's population suffers from AMD. With the increasing aging of the global population, the health and medical expenses for AMD treatment in various countries will also increase year by year. Clinically, AMD is divided into atrophic (dry) and exudative (wet) according to different phenotypes, mainly in patients with dry AMD, and dry AM...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More